
Unsu Jung
Supervisory Patent Examiner (ID: 243, Phone: (571)272-8506 , Office: P/3737 )
| Most Active Art Unit | 1641 |
| Art Unit(s) | 3737, 1641, 3768, 3792 |
| Total Applications | 405 |
| Issued Applications | 104 |
| Pending Applications | 4 |
| Abandoned Applications | 296 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5720791
[patent_doc_number] => 20060073566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Active modified hedgehog proteins'
[patent_app_type] => utility
[patent_app_number] => 11/273989
[patent_app_country] => US
[patent_app_date] => 2005-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 7523
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20060073566.pdf
[firstpage_image] =>[orig_patent_app_number] => 11273989
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/273989 | Active modified hedgehog proteins | Nov 14, 2005 | Abandoned |
Array
(
[id] => 5913559
[patent_doc_number] => 20060128621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Pharmaceutical composition of hydrophobically modified hedgehog proteins and their use'
[patent_app_type] => utility
[patent_app_number] => 11/273724
[patent_app_country] => US
[patent_app_date] => 2005-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4212
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20060128621.pdf
[firstpage_image] =>[orig_patent_app_number] => 11273724
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/273724 | Pharmaceutical composition of hydrophobically modified hedgehog proteins and their use | Nov 13, 2005 | Abandoned |
Array
(
[id] => 4797182
[patent_doc_number] => 20080008768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'Compositions and Methods for Inhibiting Sonic Hedgehog Activity'
[patent_app_type] => utility
[patent_app_number] => 11/718752
[patent_app_country] => US
[patent_app_date] => 2005-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6033
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20080008768.pdf
[firstpage_image] =>[orig_patent_app_number] => 11718752
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/718752 | Compositions and Methods for Inhibiting Sonic Hedgehog Activity | Nov 8, 2005 | Abandoned |
Array
(
[id] => 5637464
[patent_doc_number] => 20060068437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Meg-3 protein'
[patent_app_type] => utility
[patent_app_number] => 11/242604
[patent_app_country] => US
[patent_app_date] => 2005-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11889
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20060068437.pdf
[firstpage_image] =>[orig_patent_app_number] => 11242604
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/242604 | Meg-3 protein | Oct 2, 2005 | Abandoned |
Array
(
[id] => 5272095
[patent_doc_number] => 20090075871
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2009-03-19
[patent_title] => 'Modified Thioredoxin'
[patent_app_type] => utility
[patent_app_number] => 10/551488
[patent_app_country] => US
[patent_app_date] => 2005-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5118
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A2/0075/20090075871.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551488
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551488 | Modified Thioredoxin | Sep 28, 2005 | Abandoned |
Array
(
[id] => 5272095
[patent_doc_number] => 20090075871
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2009-03-19
[patent_title] => 'Modified Thioredoxin'
[patent_app_type] => utility
[patent_app_number] => 10/551488
[patent_app_country] => US
[patent_app_date] => 2005-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5118
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A2/0075/20090075871.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551488
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551488 | Modified Thioredoxin | Sep 28, 2005 | Abandoned |
Array
(
[id] => 5436482
[patent_doc_number] => 20090171069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'Peptides And Apl-Type Derivatives Of Hsp60 And Pharmaceutical Compositions'
[patent_app_type] => utility
[patent_app_number] => 11/663603
[patent_app_country] => US
[patent_app_date] => 2005-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11806
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20090171069.pdf
[firstpage_image] =>[orig_patent_app_number] => 11663603
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/663603 | Altered peptide ligand derived from HSP60 and pharmaceutical compositions | Sep 21, 2005 | Issued |
Array
(
[id] => 5866052
[patent_doc_number] => 20060100183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Therapeutic agents targeting the NCCa-ATP channel and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/229236
[patent_app_country] => US
[patent_app_date] => 2005-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 24797
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20060100183.pdf
[firstpage_image] =>[orig_patent_app_number] => 11229236
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/229236 | Methods for treating spinal cord injury with a compound that inhibits a NCCa-ATP channel | Sep 15, 2005 | Issued |
Array
(
[id] => 4618966
[patent_doc_number] => 07998682
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-16
[patent_title] => 'Method for assessing atherosclerosis by measuring expression of FOS or DUSP1 in monocytes'
[patent_app_type] => utility
[patent_app_number] => 11/661714
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 18465
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/998/07998682.pdf
[firstpage_image] =>[orig_patent_app_number] => 11661714
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/661714 | Method for assessing atherosclerosis by measuring expression of FOS or DUSP1 in monocytes | Sep 1, 2005 | Issued |
Array
(
[id] => 5895396
[patent_doc_number] => 20060003935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/213024
[patent_app_country] => US
[patent_app_date] => 2005-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15025
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003935.pdf
[firstpage_image] =>[orig_patent_app_number] => 11213024
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/213024 | Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use | Aug 25, 2005 | Abandoned |
Array
(
[id] => 4739912
[patent_doc_number] => 20080233565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'PKHDL1, a homolog of the autosomal recessive kidney disease gene'
[patent_app_type] => utility
[patent_app_number] => 11/202548
[patent_app_country] => US
[patent_app_date] => 2005-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 22303
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20080233565.pdf
[firstpage_image] =>[orig_patent_app_number] => 11202548
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/202548 | PKHDL1, a homolog of the autosomal recessive kidney disease gene | Aug 11, 2005 | Abandoned |
Array
(
[id] => 6931196
[patent_doc_number] => 20050282231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Screening assays for hedgehog agonists and antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/197721
[patent_app_country] => US
[patent_app_date] => 2005-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 75619
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282231.pdf
[firstpage_image] =>[orig_patent_app_number] => 11197721
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/197721 | Hedgehog antibodies | Aug 2, 2005 | Issued |
Array
(
[id] => 5277951
[patent_doc_number] => 20090130083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'Therapeutic Agents Targeting the NCCA-ATP Channel and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/574793
[patent_app_country] => US
[patent_app_date] => 2005-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 39894
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20090130083.pdf
[firstpage_image] =>[orig_patent_app_number] => 11574793
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/574793 | Therapeutic methods that target the NC | Jul 24, 2005 | Issued |
Array
(
[id] => 7243509
[patent_doc_number] => 20050271656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Methods for designing specific ion channel blockers'
[patent_app_type] => utility
[patent_app_number] => 11/187558
[patent_app_country] => US
[patent_app_date] => 2005-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7977
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0271/20050271656.pdf
[firstpage_image] =>[orig_patent_app_number] => 11187558
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/187558 | Methods for designing specific ion channel blockers | Jul 21, 2005 | Abandoned |
Array
(
[id] => 5539672
[patent_doc_number] => 20090221477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'Linkers'
[patent_app_type] => utility
[patent_app_number] => 11/658526
[patent_app_country] => US
[patent_app_date] => 2005-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 9568
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20090221477.pdf
[firstpage_image] =>[orig_patent_app_number] => 11658526
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/658526 | Linkers | Jul 17, 2005 | Abandoned |
Array
(
[id] => 5373681
[patent_doc_number] => 20090311242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 2a receptor (5ht2a)'
[patent_app_type] => utility
[patent_app_number] => 11/658843
[patent_app_country] => US
[patent_app_date] => 2005-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 36798
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20090311242.pdf
[firstpage_image] =>[orig_patent_app_number] => 11658843
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/658843 | Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 2a receptor (5ht2a) | Jul 17, 2005 | Abandoned |
Array
(
[id] => 5074789
[patent_doc_number] => 20070014764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Reduction in myocardial infarction size'
[patent_app_type] => utility
[patent_app_number] => 11/183251
[patent_app_country] => US
[patent_app_date] => 2005-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12402
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20070014764.pdf
[firstpage_image] =>[orig_patent_app_number] => 11183251
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/183251 | Reduction in myocardial infarction size | Jul 17, 2005 | Abandoned |
Array
(
[id] => 5767797
[patent_doc_number] => 20060019346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Identification of a novel bitter taste receptor T2R76 that specifically responds to brucine and prop bitter ligands'
[patent_app_type] => utility
[patent_app_number] => 11/182942
[patent_app_country] => US
[patent_app_date] => 2005-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21486
[patent_no_of_claims] => 107
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019346.pdf
[firstpage_image] =>[orig_patent_app_number] => 11182942
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/182942 | Identification of a novel bitter taste receptor T2R76 that specifically responds to brucine and prop bitter ligands | Jul 17, 2005 | Abandoned |
Array
(
[id] => 5210424
[patent_doc_number] => 20070249008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => 'Cardiovascular Prognostic and Diagnostic Marker'
[patent_app_type] => utility
[patent_app_number] => 11/631624
[patent_app_country] => US
[patent_app_date] => 2005-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10916
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20070249008.pdf
[firstpage_image] =>[orig_patent_app_number] => 11631624
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/631624 | Cardiovascular Prognostic and Diagnostic Marker | Jul 14, 2005 | Abandoned |
Array
(
[id] => 800470
[patent_doc_number] => 07425614
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-16
[patent_title] => 'Neuroprotective therapeutics preventing ERK/MAPK activation through the NMDA receptor'
[patent_app_type] => utility
[patent_app_number] => 11/181330
[patent_app_country] => US
[patent_app_date] => 2005-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 15
[patent_no_of_words] => 27614
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/425/07425614.pdf
[firstpage_image] =>[orig_patent_app_number] => 11181330
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/181330 | Neuroprotective therapeutics preventing ERK/MAPK activation through the NMDA receptor | Jul 13, 2005 | Issued |